Clinical Trial

Medication Adherence Program

Study acronym: MAP
Recruiting
View on ClinicalTrials.gov →
Summary
Randomized controlled trial testing the efficacy of the Supporting Tailored Adaptive change and Reinforcement for Medication Adherence Program (STAR-MAP), a health coaching approach that aims to improve antihypertensive medication adherence, blood pressure control, and quality of life. Participants (n=402) \>=40 years old with a diagnosis of hypertension, uncontrolled blood pressure, and low antihypertensive medication adherence will be recruited through a statewide health insurer, Blue Cross Blue Shield of Louisiana, and randomized to receive either interactive health coaching sessions with medication reminder tools (intervention) or medication reminder tools only (control) over one year. Data will be collected from participants at baseline, 6 months, 12 months, and 24 months using questionnaires, physical measurement (height, weight, blood pressure), a computer-based single-category implicit association test, and laboratory analysis of antihypertensive medication urinary metabolites.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2027-06-30 -> 2027-04-30 2026-06-13
minor Completion moved earlier: 2027-06-30 -> 2027-04-30 2026-06-13
Trial Details
NCT Number NCT05183763
Lead Sponsor Tulane University
Collaborators: Ohio State University, Minds at Work, National Heart, Lung, and Blood Institute (NHLBI)
Conditions Hypertension, Medication Adherence, Behavior and Behavior Mechanisms
Enrollment 402 participants
Start Date 2022-03-07
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-12